Rashida Monique Johnson

Array ( [id] => 3627422 [patent_doc_number] => 05621078 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Modified pseudomonas exotoxin PE.sub.40' [patent_app_type] => 1 [patent_app_number] => 8/391259 [patent_app_country] => US [patent_app_date] => 1995-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7685 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/621/05621078.pdf [firstpage_image] =>[orig_patent_app_number] => 391259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3895566 [patent_doc_number] => 05750502 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Cloning, expression and uses of a secreted protein, F-spondin' [patent_app_type] => 1 [patent_app_number] => 8/313288 [patent_app_country] => US [patent_app_date] => 1995-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 40 [patent_no_of_words] => 15798 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750502.pdf [firstpage_image] =>[orig_patent_app_number] => 313288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3705982 [patent_doc_number] => 05654267 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Cooperative combinations of ligands contained within a matrix' [patent_app_type] => 1 [patent_app_number] => 8/347942 [patent_app_country] => US [patent_app_date] => 1994-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 11016 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654267.pdf [firstpage_image] =>[orig_patent_app_number] => 347942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3780997 [patent_doc_number] => 05821084 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Osteoblast-testicular protein tyrosine phosphatase' [patent_app_type] => 1 [patent_app_number] => 8/342930 [patent_app_country] => US [patent_app_date] => 1994-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13862 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821084.pdf [firstpage_image] =>[orig_patent_app_number] => 342930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3591216 [patent_doc_number] => 05585463 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => '.beta..sub.3 integrin subunit specific polypeptides, cDNAs which encode these polypeptides and method of producing these polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/338009 [patent_app_country] => US [patent_app_date] => 1994-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3763 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585463.pdf [firstpage_image] =>[orig_patent_app_number] => 338009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3666405 [patent_doc_number] => 05599792 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Bone-stimulating, non-vasoactive parathyroid hormone variants' [patent_app_type] => 1 [patent_app_number] => 8/332453 [patent_app_country] => US [patent_app_date] => 1994-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 6364 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599792.pdf [firstpage_image] =>[orig_patent_app_number] => 332453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685905 [patent_doc_number] => 05643749 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Soluble interferon .alpha.-receptor, its preparation and use' [patent_app_type] => 1 [patent_app_number] => 8/328256 [patent_app_country] => US [patent_app_date] => 1994-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 9583 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643749.pdf [firstpage_image] =>[orig_patent_app_number] => 328256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3660871 [patent_doc_number] => 05648332 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Method of treating diabetes mellitus using variable .alpha. domain of T-cell receptor' [patent_app_type] => 1 [patent_app_number] => 8/318881 [patent_app_country] => US [patent_app_date] => 1994-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4128 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648332.pdf [firstpage_image] =>[orig_patent_app_number] => 318881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692341 [patent_doc_number] => 05679546 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Chimeric proteins which block complement activation' [patent_app_type] => 1 [patent_app_number] => 8/310416 [patent_app_country] => US [patent_app_date] => 1994-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 13133 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679546.pdf [firstpage_image] =>[orig_patent_app_number] => 310416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3792606 [patent_doc_number] => 05726152 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Vascular endothelial cell growth factor II' [patent_app_type] => 1 [patent_app_number] => 8/299185 [patent_app_country] => US [patent_app_date] => 1994-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 34 [patent_no_of_words] => 12854 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726152.pdf [firstpage_image] =>[orig_patent_app_number] => 299185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730745 [patent_doc_number] => 05652343 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Method for purification of L-selectin ligands' [patent_app_type] => 1 [patent_app_number] => 8/294675 [patent_app_country] => US [patent_app_date] => 1994-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 22691 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652343.pdf [firstpage_image] =>[orig_patent_app_number] => 294675 [rel_patent_id] =>[rel_patent_doc_number] =>)